Gains access to additional capabilities and markets.

Charles River recently announced plans to acquire WIL Research, a premier provider of safety assessment and contract development and manufacturing services to biopharmaceutical, agricultural and industrial chemical companies worldwide.

Additionally, in the fourth quarter of 2015, Oncotest, a Germany-based contract research organization providing discovery services for oncology, became part of the Charles River portfolio.

According to Charles River, these acquisitions deliver additional scientific capabilities and access to global markets to better serve its customers.

 

 

Recent Posts

We Are Testing at HPCI India 2025

HPCI India has been an Industry-Connect Partner for 10+ years and has established itself as…

ADAT, experts in clinical data certification and analysis since 25 years

Welcome to ADAT Europe At ADAT, we are dedicated to providing state-of-the-art solutions in data…

We Are Testing at in-cosmetics Asia 2024 – The best place to talk about testing

in-cosmetics Asia is the leading personal care and cosmetic ingredient event in Asia Pacific, bringing…